Arrowhead Pharmaceuticals, Inc. (ARWR)
63.59
-0.27
(-0.42%)
USD |
NASDAQ |
Feb 20, 16:00
63.58
-0.01
(-0.02%)
After-Hours: 20:00
Arrowhead Pharmaceuticals SG&A Expense (Quarterly) : 46.02M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 91.89M |
| Sanofi | -- |
| Eli Lilly & Co. | 3.132B |
| Cidara Therapeutics, Inc. | 8.099M |
| Celcuity, Inc. | 7.934M |